Combination chemotherapy with clofarabine, cyclophosphamide, and etoposide in children with refractory or relapsed haematological malignancies.
作者信息
Inaba Hiroto, Bhojwani Deepa, Pauley Jennifer L, Pei Deqing, Cheng Cheng, Metzger Monika L, Howard Scott C, Rubnitz Jeffrey E, Sandlund John T, Ribeiro Raul C, Leung Wing, Campana Dario, Pui Ching-Hon, Jeha Sima
出版信息
Br J Haematol. 2012 Jan;156(2):275-9. doi: 10.1111/j.1365-2141.2011.08847.x. Epub 2011 Aug 25.
Abstract
摘要
相似文献
1
Combination chemotherapy with clofarabine, cyclophosphamide, and etoposide in children with refractory or relapsed haematological malignancies.氯法拉滨、环磷酰胺和依托泊苷联合化疗用于难治性或复发性血液系统恶性肿瘤儿童患者
Br J Haematol. 2012 Jan;156(2):275-9. doi: 10.1111/j.1365-2141.2011.08847.x. Epub 2011 Aug 25.
2
A multi-center phase I study of clofarabine, etoposide and cyclophosphamide in combination in pediatric patients with refractory or relapsed acute leukemia.一项关于克拉屈滨、依托泊苷和环磷酰胺联合治疗难治性或复发性急性白血病患儿的多中心 I 期研究。
Leukemia. 2009 Dec;23(12):2259-64. doi: 10.1038/leu.2009.185. Epub 2009 Sep 10.
3
Phase 2 trial of clofarabine in combination with etoposide and cyclophosphamide in pediatric patients with refractory or relapsed acute lymphoblastic leukemia.儿童难治性或复发急性淋巴细胞白血病患者中用克拉屈滨联合依托泊苷和环磷酰胺进行的 2 期临床试验。
Blood. 2011 Dec 1;118(23):6043-9. doi: 10.1182/blood-2011-08-374710. Epub 2011 Oct 3.
4
Clofarabine, cyclophosphamide and etoposide as single-course re-induction therapy for children with refractory/multiple relapsed acute lymphoblastic leukaemia.用克拉屈滨、环磷酰胺和依托泊苷进行单疗程再诱导治疗，用于治疗耐药/多重复发的急性淋巴细胞白血病患儿。
Br J Haematol. 2009 Nov;147(3):371-8. doi: 10.1111/j.1365-2141.2009.07882.x. Epub 2009 Aug 29.
5
Combination of clofarabine, cyclophosphamide, and etoposide for relapsed or refractory childhood and adolescent acute myeloid leukemia.氯法拉滨、环磷酰胺和依托泊苷联合用于复发或难治性儿童及青少年急性髓系白血病
Pediatr Hematol Oncol. 2017 May;34(4):187-198. doi: 10.1080/08880018.2017.1360970. Epub 2017 Oct 17.
6
A phase I trial of high-dose clofarabine, etoposide, and cyclophosphamide and autologous peripheral blood stem cell transplantation in patients with primary refractory and relapsed and refractory non-Hodgkin lymphoma.一项Ⅰ期临床试验，评估高剂量克拉屈滨、依托泊苷和环磷酰胺联合自体外周血造血干细胞移植治疗原发性耐药和复发/难治性非霍奇金淋巴瘤的疗效。
Biol Blood Marrow Transplant. 2011 Jul;17(7):987-94. doi: 10.1016/j.bbmt.2010.10.016. Epub 2010 Oct 20.
7
[Clofarabine-based combination chemotherapy for relapse and refractory childhood acute lymphoblastic leukemia].基于氯法拉滨的联合化疗用于复发和难治性儿童急性淋巴细胞白血病
Rinsho Ketsueki. 2014 Nov;55(11):2316-9.
8
Clofarabine, cyclophosphamide and etoposide for the treatment of relapsed or resistant acute leukemia in pediatric patients.用克拉屈滨、环磷酰胺和依托泊苷治疗儿科患者复发或耐药性急性白血病。
Leuk Lymphoma. 2012 Sep;53(9):1693-8. doi: 10.3109/10428194.2012.663915. Epub 2012 Mar 13.
9
Refractory acute lymphoblastic leukemia in Chinese children: bridging to stem cell transplantation with clofarabine, cyclophosphamide and etoposide.中国儿童难治性急性淋巴细胞白血病：通过氯法拉滨、环磷酰胺和依托泊苷过渡到干细胞移植
Ann Hematol. 2016 Feb;95(3):501-7. doi: 10.1007/s00277-015-2577-7. Epub 2015 Dec 15.
10
A clofarabine-based bridging regimen in patients with relapsed ALL and persistent minimal residual disease (MRD).复发急性淋巴细胞白血病（ALL）合并持续性微小残留病（MRD）患者的基于氯法拉滨的桥接方案
Bone Marrow Transplant. 2014 Mar;49(3):440-2. doi: 10.1038/bmt.2013.195. Epub 2013 Dec 9.
引用本文的文献
1
Clofarabine in Pediatric Acute Relapsed or Refractory Leukemia: Where Do We Stand on the Bridge to Hematopoietic Stem Cell Transplantation?氯法拉滨用于小儿急性复发或难治性白血病：在通往造血干细胞移植之路上我们处于什么位置？
J Hematol. 2023 Feb;12(1):16-26. doi: 10.14740/jh1065. Epub 2023 Feb 25.
2
Successful combination chemotherapy involving clofarabine, cyclophosphamide, and etoposide for pediatric relapsed acute myeloid leukemia: A case report.成功应用氯法拉滨、环磷酰胺和依托泊苷联合化疗治疗儿童复发性急性髓系白血病：1例报告
SAGE Open Med Case Rep. 2021 May 13;9:2050313X211015511. doi: 10.1177/2050313X211015511. eCollection 2021.
3
Phase 1 study of bendamustine in combination with clofarabine, etoposide, and dexamethasone in pediatric patients with relapsed or refractory hematologic malignancies.儿童复发或难治性血液系统恶性肿瘤患者中苯达莫司汀联合克拉屈滨、依托泊苷和地塞米松的 1 期研究。
Cancer. 2021 Jun 15;127(12):2074-2082. doi: 10.1002/cncr.33465. Epub 2021 Feb 17.
4
Cellular and Antibody Based Approaches for Pediatric Cancer Immunotherapy.用于儿科癌症免疫治疗的基于细胞和抗体的方法。
J Immunol Res. 2015;2015:675269. doi: 10.1155/2015/675269. Epub 2015 Oct 26.
5
Natural killer cell therapy in children with relapsed leukemia.复发白血病患儿的自然杀伤细胞疗法
Pediatr Blood Cancer. 2015 Aug;62(8):1468-72. doi: 10.1002/pbc.25555. Epub 2015 Apr 30.
6
Overview of therapy and strategies for optimizing outcomes in de novo pediatric acute myeloid leukemia.初诊儿童急性髓系白血病的治疗概述及优化治疗效果的策略
Paediatr Drugs. 2014 Jun;16(3):213-27. doi: 10.1007/s40272-014-0067-3.
7
Relapsed and refractory pediatric acute myeloid leukemia: current and emerging treatments.复发难治性儿童急性髓系白血病：现有及新出现的治疗方法。
Paediatr Drugs. 2014 Apr;16(2):151-68. doi: 10.1007/s40272-013-0048-y.
8
French "real life" experience of clofarabine in children with refractory or relapsed acute lymphoblastic leukaemia.法国儿童难治/复发急性淋巴细胞白血病应用克拉屈滨的真实世界经验。
Exp Hematol Oncol. 2012 Dec 10;1(1):39. doi: 10.1186/2162-3619-1-39.
9
Childhood acute myeloid leukaemia.儿童急性髓系白血病。
Br J Haematol. 2012 Nov;159(3):259-76. doi: 10.1111/bjh.12040. Epub 2012 Sep 12.
10
Anti-leukemic mechanisms of pegylated arginase I in acute lymphoblastic T-cell leukemia.聚乙二醇化精氨酸酶 I 在急性淋巴细胞性 T 细胞白血病中的抗白血病机制。
Leukemia. 2013 Mar;27(3):569-77. doi: 10.1038/leu.2012.247. Epub 2012 Aug 28.
本文引用的文献
1
Early UK experience in the use of clofarabine in the treatment of relapsed and refractory paediatric acute lymphoblastic leukaemia.英国在使用克拉屈滨治疗复发/难治性儿童急性淋巴细胞白血病方面的早期经验。
Br J Haematol. 2011 Aug;154(4):482-5. doi: 10.1111/j.1365-2141.2011.08752.x. Epub 2011 Jun 21.
2
Clofarabine, cyclophosphamide and etoposide as single-course re-induction therapy for children with refractory/multiple relapsed acute lymphoblastic leukaemia.用克拉屈滨、环磷酰胺和依托泊苷进行单疗程再诱导治疗，用于治疗耐药/多重复发的急性淋巴细胞白血病患儿。
Br J Haematol. 2009 Nov;147(3):371-8. doi: 10.1111/j.1365-2141.2009.07882.x. Epub 2009 Aug 29.
3
A multi-center phase I study of clofarabine, etoposide and cyclophosphamide in combination in pediatric patients with refractory or relapsed acute leukemia.一项关于克拉屈滨、依托泊苷和环磷酰胺联合治疗难治性或复发性急性白血病患儿的多中心 I 期研究。
Leukemia. 2009 Dec;23(12):2259-64. doi: 10.1038/leu.2009.185. Epub 2009 Sep 10.
4
Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM Study Group.异基因干细胞移植前微小残留病定量在儿童复发性急性淋巴细胞白血病中的预后价值：ALL-REZ BFM研究组
J Clin Oncol. 2009 Jan 20;27(3):377-84. doi: 10.1200/JCO.2008.17.6065. Epub 2008 Dec 8.
5
Prophylactic antibiotics reduce morbidity due to septicemia during intensive treatment for pediatric acute myeloid leukemia.预防性抗生素可降低小儿急性髓系白血病强化治疗期间败血症所致的发病率。
Cancer. 2008 Jul 15;113(2):376-82. doi: 10.1002/cncr.23563.
6
Results of a phase 1-2 study of clofarabine in combination with cytarabine (ara-C) in relapsed and refractory acute leukemias.氯法拉滨联合阿糖胞苷（ara-C）治疗复发和难治性急性白血病的1-2期研究结果。
Blood. 2005 Feb 1;105(3):940-7. doi: 10.1182/blood-2004-05-1933. Epub 2004 Oct 14.
7
8
Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia.儿童急性淋巴细胞白血病微小残留病的临床重要性
Blood. 2000 Oct 15;96(8):2691-6.
Zotero 插件